申请人:UNIV NOTTINGHAM
公开号:WO2021156607A1
公开(公告)日:2021-08-12
The invention relates to methods of producing solid drug formulations using advanced manufacturing techniques, such as 3D printing, where there is a requirement for low viscosity. The invention uses a photo-reactive material in liquid form, the photo-reactive material comprising: (a) prodrug monomer that comprises an active pharmaceutical ingredient in a prodrug form, in which the active pharmaceutical ingredient is releasably attached to a polymerisable group via a releasable covalent bond, and, optionally, (b) diluent monomer that comprises a polymerisable group.
这项发明涉及使用先进制造技术(如3D打印)生产固体药物配方的方法,其中需要低粘度。该发明使用液态光敏材料,该光敏材料包括:(a)前药单体,其中包括以前药形式存在的活性药物成分,其中活性药物成分通过可释放的共价键与可聚合基团结合,以及可选的(b)稀释剂单体,其中包括可聚合基团。